— Know what they know.
Not Investment Advice

FEMY NASDAQ

Femasys Inc.
1W: -16.1% 1M: -32.9% 3M: -49.0% YTD: -83.7% 1Y: -72.3% 3Y: -90.6% 5Y: -98.6%
$2.05
-0.05 (-2.38%)
 
Weekly Expected Move ±9.6%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 34 · $6.2M mcap · 2M float · 21.65% daily turnover · Short 24% of daily vol

Balance Sheet Trends

Total Assets
$12M -55.2% ▼
5Y CAGR: -0.3%
Total Liabilities
$10M +7.8% ▲
5Y CAGR: -29.4%
Shareholders Equity
$2M -87.4% ▼
Cash & Investments
$3M -84.1% ▼
5Y CAGR: -14.2%
Total Debt
$7M +11.1% ▲
5Y CAGR: +34.2%
Net Debt
$4M +126.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3M$25M$13M$22M$3M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3M$25M$13M$22M$3M
Net Receivables$126K$84K$77K$99K$488K
Inventory$131K$208K$437K$667K$3M
Other Current Assets$284K$556K$655K$696K$1M
Total Current Assets$4M$26M$14M$23M$8M
Property, Plant & Equip.$3M$2M$2M$3M$3M
Goodwill & Intangibles$65K$25K$3K$0$66K
Long-Term Investments$0-$20M$0$0$0
Other Non-Current Assets$792K$655K$958K$1M$955K
Total Non-Current Assets$4M$3M$3M$5M$4M
Total Assets$8M$29M$17M$28M$12M
— Liabilities —
Accounts Payable$674K$446K$511K$1M$1M
Short-Term Debt$630K$181K$141K$0$5M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$33K$55K$417K$1M$89K
Total Current Liabilities$3M$2M$2M$3M$9M
Long-Term Debt$182K$0$0$4M$0
Other Non-Current Liab.$198K$150K$97K$55K$40K
Total Non-Current Liabilities$1M$552K$125K$6M$2M
Total Liabilities$4M$2M$2M$9M$10M
— Equity —
Common Stock$1K$12K$12K$22K$23K
Retained Earnings-$75M-$83M-$94M-$108M-$127M
Accumulated OCI$702K$702K$568K$3M$2M
Total Stockholders Equity$4M$26M$15M$18M$2M
Total Liabilities & Equity$8M$29M$17M$28M$12M
— Key Metrics —
Total Debt$2M$990K$544K$7M$7M
Net Debt-$1M-$24M-$12M-$15M$4M
Total Investments$0-$20M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms